Toxicological studies and antimicrobial properties of some Iron(III) complexes of Ciprofloxacin

African Journal of Biotechnology

Volumn 6, Issue 24, 2007, Pages 2826-2832

  Obaleye, J A ^a   Akinremi, C A ^b   Balogun, E A ^a   Adebayo, J O ^a  

^a UNIVERSITY OF ILORIN   (Nigeria)

^b Federal College of Education   (Nigeria)

Author keywords

Antimicrobial study; Ciprofloxacin; Fluoroquinolone; Metal complexes; Quinolone; Toxicological study

Indexed keywords

CIPROFLOXACIN; CIPROFLOXACINIUM TETRACHLOROFERRATE CHLORIDE; DI(CIPROFLOXACIN)DICHLOROIRON CHLORIDE; IRON COMPLEX; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BODY WEIGHT; COMPLEX FORMATION; CONTROLLED STUDY; DRUG SYNTHESIS; ESCHERICHIA COLI; KLEBSIELLA; LIVER WEIGHT; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PSEUDOMONAS; RAT; SALMONELLA TYPHI; SHIGELLA; STAPHYLOCOCCUS AUREUS; TOXICITY TESTING;

RATTUS;

EID: 37549021483     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: 10.5897/ajb2007.000-2451     Document Type: Article

References (17)

1. Al-Mustafa J (2002). Magnesium, Calcium and Barium Percholate complexes of ciprofloxacin and Norfloxacin. Acta. Chim. Slov. 49: 457-466.
2. Akanji MA, Olagoke OA, Oloyede OB (1993). Effects of chronic consumption of metabisulphite on the integrity of the rat kidney cellular system. Toxicol. 81:173-179.
3. rd Ed). W.B.Saunders Company, Pennnsylvannia, U.S.A. 2&3: 634-713, 1168.
4. Chu DTW, Plattner JJ, Katz L (1996). J New Directions in Antibacterial Research. J. Med.Chem. 39(20): 3853-3873.
5. nd Ed) Churchill Livingstone, Edinburgh.pp C230-234, N137-141, 07-12.
6. Drevenski P, Golobic A, Turel I, Poklar N, Sepcic K (2002). Crystal Structure, Characterization and biological activity of Copper(II)-Ciprofloxacin ionic compound. Acta. Chim. Slov 49: 857-870.
7. Kucers A, Mck.Bennet N (1987). The use of Antibiotics, Heinemann Medical Books: Oxford.
8. Malomo SO, Ale OO, Adedoyin AM (1993). Effect of chloroquine on some leukocyte enzymes during protein energy malnutrition- an in vitro study. Biosci. Res. Commun. 5: 53-55.
9. Malomo SO, Daramola AS, Balogun EA (1995). Some serum and tissue enzyme changes in mice infected with Plasmodium yoelii nigeriensis before and after administration of halofantrine hydrochloride. Niger. J. Biochem. Mol. Biol. 10:71-77.
10. Randox Laboratories Ltd. UK. Randox Enzyme assay manual (1997). ACP, ALP, GOT, GPT.
11. th Ed., John Wiley and Sons Ltd: England, p. 329.
12. Turel I, Gruber K, Leban I, Bukovec N (1996). Synthesis, Crystal structure and Characterization of three novel compounds of the quinolone family member (Norfloxacin). J. Inorgan. Biochem. 61: 197-212.
13. Turel I (2002). The interaction of metal ions with quinolone antibacterial agents. Coord. Chem. Rev 232: 27-47.
14. Turel I, Colobic A, Klavar A, Pihlar B, Buglyo P, Tolis E, Rehder D, Sepcic K (2003). Interactions of oxovanadium(VI) and the quinolone family member- Ciprofloxacin. J. Inorgan. Biochem. 95: 199-207.
15. Umezawa H, Hooper IR (1982). Aminoglycoside antibiotics. Spinger-Verky, Berlin, Hadelberg.
16. Wise R, Andrews JM, Edwards LJ (1983). In vitro Activity of Bay 09867, a New Quinoline Derivative, Compared with those of other Antimicrobial Agents. Antimicrob. Agents. Chem. 23(4): 559-564.
17. 2O. Croatica. Chem. Acta 74(1): 61-74.